Medtech / devices
Corsera Health has raised US$80m in Series A funding to develop preventive RNAi medicines and AI tools to predict and prevent cardiovascular disease. The Boston-based company has begun dosing patients in a Phase 1 clinical trial of COR-1004, a drug designed to lower cholesterol by silencing PCSK9, a gene that regulates LDL cholesterol in the [...]
Captify won AARP’s AgeTech pitch at CES, taking US$10,000 for captioning glasses that show real-time subtitles for people with hearing loss. San Francisco-based Captify beat four other AgeTech firms at the 2026 AgeTech After Dark event. The glasses show captions in the wearer’s field of view and are claimed to be 98 per cent accurate, [...]
We round up the latest ageing and longevity investment news. Regenerative cellular medicine company Celularity Inc has secured a US$10m financing package to support its healthy-ageing innovations. The NASDAQ-listed business which focuses on addressing age-related and degenerative diseases secured the financing from Philip Barach, co-founder and former president of US investment house DoubleLine Capital. “This [...]
The US Food and Drug Administration (FDA) has cleared an automated brain fluid device designed to help ease intensive care nursing shortages. Seattle-based BrainSpace said its Intellidrop system integrates hardware and software to enable continuous brain pressure measurement and closed-loop, gravity-driven drainage of cerebrospinal fluid, the liquid that surrounds and cushions the brain and spinal [...]
Insilico has signed a multi-year US$888m oncology deal with Servier to use AI in discovering and developing cancer therapies. The AI-driven drug discovery company will use its Pharma.AI platform to identify and advance potential drug candidates, while Servier will lead clinical validation, regulatory interactions and worldwide commercialisation. Under the agreement, Insilico will be eligible to [...]
Agetech World explores the latest business developments in the world of ageing and longevity. AI app tackles dementia-related loneliness Amicus Brain Innovations has launched Amicus INTERACT. The AI-powered app is designed to provide real-time guidance that enables meaningful conversations and helps reduce the social isolation often caused by memory loss and communication challenges. As dementia [...]
Researchers say a molecule from gut bacteria may counter insulin resistance in type 2 diabetes. The study reports that trimethylamine (TMA), made by gut microbes from dietary choline, can block a key immune pathway and improve blood sugar control. Scientists found that TMA acts as a natural inhibitor of IRAK4, a protein that drives inflammation [...]
Agetech World explores the latest business developments in the world of ageing and longevity. US$4.5m NIH Funding for senior care technology Immersive technology company Rendever has secured nearly US$4.5m in grant funding from the National Institutes of Health (NIH) to improve the ageing process through technology-enabled social networks. The funding includes US$3.8m for the Thrive [...]
Developed with input from over 13,000 participants a new, AI-powered, speech and language software has the potential to speed-up dementia diagnoses, whilst reducing the cost. Memory Tell stems from the work of neuroscientist Adolfo Garcia, Co-founder of the Global Brain Health Institute (GBHI), who, for the last 15 years, has been investigating dementia, digital-biomarkers. In [...]
Age Tech World explores the latest research developments in the world of longevity and ageing. Pushing the frontiers of generative AI for longevity AI- driven drug discovery and development company Insilico Medicine is launching an innovative cardiometabolic disease portfolio of unique highly-differentiated molecules discovered using generative AI. Powered by Insilico’s proprietary end-to-end Pharma.AI platform, the [...]
